Chronic myeloid leukemia (CML) is a hematopoietic malignancy defined by the BCR-ABL fusion protein encoded by the Philadelphia chromosome (Ph)[1]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.